J Korean Assoc Oral Maxillofac Surg.  2016 Jun;42(3):157-161. 10.5125/jkaoms.2016.42.3.157.

Dental implant treatment after healing of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in the same region: a case report

Affiliations
  • 1Department of Oral and Maxillofacial Surgery, Asan Medical Center, Seoul, Korea. mfsjjh@unitel.co.kr
  • 2Department of Prosthodontics, Asan Medical Center, Seoul, Korea.

Abstract

Although pathophysiology, incidence, and factors associated with the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ) and management strategies for patients treated with bisphosphonates or patients with BRONJ are well-established, few guidelines or recommendations are available for patients with a history of successfully healed BRONJ. We present a case of successful dental implant treatment after healing of BRONJ in the same region of the jaw, and speculate that implant placement is possible after healing of BRONJ surgery in select cases.

Keyword

Reimplantation; Dental implants; Bisphosphonate-associated osteonecrosis of the jaw; Osteonecrosis; Bisphosphonates

MeSH Terms

Bisphosphonate-Associated Osteonecrosis of the Jaw*
Dental Implants*
Diphosphonates
Humans
Incidence
Jaw
Osteonecrosis
Replantation
Dental Implants
Diphosphonates

Figure

  • Fig. 1 Intraoral photograph (A) and panoramic radiograph (B) at the first visit (March 2013).

  • Fig. 2 Intraoral photograph during surgery (May 2013).

  • Fig. 3 Implant removal and conventional bridge prosthesis was rehabilitated.

  • Fig. 4 Intraoral photograph of the necrotic bone exposure in the upper left molar area.

  • Fig. 5 Panoramic radiograph (A) and intraoral photograph (B) before re-implantation (October 2014).

  • Fig. 6 Panoramic radiograph after re-implantation.

  • Fig. 7 (A, B) Intraoral photographs after loading at 4 months (July 2015).


Cited by  1 articles

The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction
Sang-Hoon Kang, Se-Jin Park, Moon-Key Kim
J Korean Assoc Oral Maxillofac Surg. 2020;46(1):78-83.    doi: 10.5125/jkaoms.2020.46.1.78.


Reference

1. Kushner GM, Alpert B. Osteomyelitis, osteoradionecrosis and BRONJ. In : Miloro M, Ghali GE, Larsen PE, Waite PD, editors. Peterson's principles of oral and maxillofacial surgery. 3rd ed. Shelton: People's medical publishing house;2012. p. 861–874.
2. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg. 2009; 67(5 Suppl):2–12. PMID: 19371809.
Article
3. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007; 65:369–376. PMID: 17307580.
4. Marx RE. Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention, and treatment. 2nd ed. Chicago: Quintessence Publishing;2011.
5. Rasmusson L, Abtahi J. Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. Int J Dent. 2014; 2014:471035. PMID: 25254048.
Article
6. Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 2015; 44:568–585. PMID: 25726090.
Article
7. Tallarico M, Canullo L, Xhanari E, Meloni SM. Dental implants treatment outcomes in patient under active therapy with alendronate: 3-year follow-up results of a multicenter prospective observational study. Clin Oral Implants Res. 2015; DOI: 10.1111/clr.12662. [Epub ahead of print].
Article
8. Rugani P, Kirnbauer B, Acham S, Truschnegg A, Jakse N. Implant placement adjacent to successfully treated bisphosphonate-related osteonecrosis of the jaw (BRONJ). J Oral Implantol. 2015; 41:377–381. PMID: 24593250.
Article
9. Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin Oral Implants Res. 2014; 25:632–640. PMID: 23278625.
Article
10. Memon S, Weltman RL, Katancik JA. Oral bisphosphonates: early endosseous dental implant success and crestal bone changes. A retrospective study. Int J Oral Maxillofac Implants. 2012; 27:1216–1222. PMID: 23057037.
11. Dixon RB, Tricker ND, Garetto LP. Bone turnover in elderly canine mandible and tibia. J Dent Res. 1997; 76:336.
12. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res. 2009; 20(Suppl 4):87–89. PMID: 19663954.
Article
13. Ata-Ali J, Ata-Ali F, Peñarrocha-Oltra D, Galindo-Moreno P. What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis. Clin Oral Implants Res. 2016; 27:e38–e46. PMID: 25406770.
Article
Full Text Links
  • JKAOMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr